Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Biospecimen Analysis in Determining Effects of Chemotherapy on Fertility in Osteosarcoma Survivors

This research trial studies saliva, semen, and blood samples to determine effects of chemotherapy on fertility in osteosarcoma survivors. Study biospecimen samples from osteosarcoma survivors in the laboratory may help doctors learn whether chemotherapy causes fertility problems and to learn more about the long term effects.
Pediatrics, Sarcoma
N/A
Adults
Not Available
Not Available
Borinstein, Scott
National
Vanderbilt University
12-03-2019
Health Services Research
COGALTE16C1
NCT03206450

Eligibility

18 Years
MALE
NO
Inclusion Criteria:

Received upfront therapies for osteosarcoma, which included cisplatin, (with or without other agents)

Patient must have completed cancer treatment >= 2 years prior to study enrollment

Osteosarcoma survivors without a systemically treated relapse or subsequent malignancy * Note: History of relapse or second malignancy is permitted if treated with local therapy only (e.g. surgery, radiation)

Able to speak, read and write in English, French or Spanish

All patients and/or their parents or legal guardians must sign a written informed consent

All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: